Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
ZVRA is expected to report earnings to fall 81.12% to 11 cents per share on August 18
Q2'26
Est.
$0.11
Q1'26
Beat
by $0.53
Q4'25
Beat
by $0.14
Q3'25
Beat
by $0.02
Q2'25
Missed
by $2.25
The last earnings report on May 06 showed earnings per share of 60 cents, beating the estimate of 7 cents. With 1.72M shares outstanding, the current market capitalization sits at 747.81M.